Covagen clinical trials

Acquired by Johnson & Johnson, 2014 · source ↗

The registry lists 1 studies whose lead sponsor is Covagen. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 1, 2016.

Before and after it joined Johnson & Johnson

First submitted before Covagen became part of Johnson & Johnson: 0
First submitted after Covagen became part of Johnson & Johnson: 0
Unclear, or no submission date: 1

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Terminated: 1

Phase

Phase 2: 1
Phase 1: 1

Where

Germany: 1

Registry sponsor names on this page

Covagen1 study

Something wrong with this grouping? Tell us on the Johnson & Johnson page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Johnson & Johnson studies →

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque PsoriasisTerminatedNCT02243787Phase 1/2
Sponsor listed in the registry: Covagen · Unclear whether first submitted before or after Covagen became part of Johnson & Johnson